368 related articles for article (PubMed ID: 17382994)
1. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease.
Tripatara A; Jetsrisuparb A; Teeratakulpisarn J; Kuaha K
Thromb Res; 2007; 120(6):805-10. PubMed ID: 17382994
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic and thrombotic markers in patients with hemoglobin E/beta-thalassemia disease.
Angchaisuksiri P; Atichartakarn V; Aryurachai K; Archararit N; Chuncharunee S; Tiraganjana A; Rattanasiri S
Am J Hematol; 2007 Nov; 82(11):1001-4. PubMed ID: 17654509
[TBL] [Abstract][Full Text] [Related]
3. Thrombin activatable fibrinolysis inhibitor (TAFI): relationship to hemostatic alteration in patients with beta-thalassemia.
Mokhtar GM; Matter RM; Shawki H; Abdel Aziz MM
Pediatr Hematol Oncol; 2010 Aug; 27(5):363-73. PubMed ID: 20670166
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic alterations in beta-thalassemia/hemoglobin E patients.
Opartkiattikul N; Tatsumi N; Funahara Y; Shirahata A; Wongtiraporn W; Tientadakul P; Fucharoen S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():86-9. PubMed ID: 10926266
[TBL] [Abstract][Full Text] [Related]
5. Protein C and protein S deficiency in thalassemic patients.
Shirahata A; Funahara Y; Opartkiattikul N; Fucharoen S; Laosombat V; Yamada K
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():65-73. PubMed ID: 1298996
[TBL] [Abstract][Full Text] [Related]
6. Significance of blood coagulation and platelet profiles in relation to pulmonary thrombosis in beta-thalassemia/Hb E.
Visudhiphan S; Ketsa-Ard K; Tumliang S; Piankijagum A
Southeast Asian J Trop Med Public Health; 1994 Sep; 25(3):449-56. PubMed ID: 7777905
[TBL] [Abstract][Full Text] [Related]
7. High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases.
Torcharus K; Withayathawornwong W; Sriphaisal T; Krutvacho T; Arnutti P; Suwanasophorn C
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():96-9. PubMed ID: 7886617
[TBL] [Abstract][Full Text] [Related]
8. [Oromaxillofacial changes in thalassemia major].
De Mattia D; Pettini PL; Sabato V; Rubini G; Laforgia A; Schettini F
Minerva Pediatr; 1996; 48(1-2):11-20. PubMed ID: 9072660
[TBL] [Abstract][Full Text] [Related]
9. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study.
Sutipornpalangkul W; Morales NP; Unchern S; Sanvarinda Y; Chantharaksri U; Fucharoen S
J Med Assoc Thai; 2012 Jan; 95(1):29-36. PubMed ID: 22379738
[TBL] [Abstract][Full Text] [Related]
11. Hypercoagulable state in five thalassemia intermedia patients.
Bhattacharyya M; Kannan M; Chaudhry VP; Mahapatra M; Pati H; Saxena R
Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195
[TBL] [Abstract][Full Text] [Related]
12. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
Koc A; Gumruk F; Gurgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615
[TBL] [Abstract][Full Text] [Related]
13. Increase in spontaneous platelet aggregation in beta-thalassemia/hemoglobin E disease: a consequence of splenectomy.
Opartkiattikul N; Funahara Y; Fucharoen S; Talalak P
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():36-41. PubMed ID: 1298991
[TBL] [Abstract][Full Text] [Related]
14. Intravascular hemolysis, vascular endothelial cell activation and thrombophilia in splenectomized patients with hemoglobin E/β-thalassemia disease.
Atichartakarn V; Chuncharunee S; Archararit N; Udomsubpayakul U; Aryurachai K
Acta Haematol; 2014; 132(1):100-7. PubMed ID: 24525823
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation and activation in thalassemia major patients in Indonesia.
Setiabudy R; Wahidiyat PA; Setiawan L
Clin Appl Thromb Hemost; 2008 Jul; 14(3):346-51. PubMed ID: 18160592
[TBL] [Abstract][Full Text] [Related]
16. A Comparison of Hemostatic Changes in Splenectomized and Nonsplenectomized β-Thalassemia Intermedia Patients.
Hashemieh M; Azarkeivan A; Sheibani K
J Pediatr Hematol Oncol; 2016 Nov; 38(8):636-641. PubMed ID: 27606436
[TBL] [Abstract][Full Text] [Related]
17. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
Gharagozloo M; Karimi M; Amirghofran Z
Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
[TBL] [Abstract][Full Text] [Related]
18. Hypercoagulable state as demonstrated by thromboelastometry in hemoglobin E/beta-thalassemia patients: Association with clinical severity and splenectomy status.
Natesirinilkul R; Charoenkwan P; Nawarawong W; Boonsri S; Tantivate P; Wongjaikum S; Manowong S; Sanguansermsri T
Thromb Res; 2016 Apr; 140():125-131. PubMed ID: 26971311
[TBL] [Abstract][Full Text] [Related]
19. Serum erythropoietin levels in pediatric patients with beta-thalassemia/hemoglobin E.
Paritpokee N; Wiwanitkit V; Bhokaisawan N; Boonchalermvichian C; Preechakas P
Clin Lab; 2002; 48(11-12):631-4. PubMed ID: 12465748
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of platelets from red cell fragments using laser technology: comparison between splenectomized and nonsplenectomized thalassemic patients.
Bunyaratvej A
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():250-2. PubMed ID: 7886588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
